UPDATED Aug 11, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RYTM | US$94.31 | 2.5% | 112.0% | US$6.1b | US$112.50 | PS40.1x | E68.6% | n/a | ||
CAI | US$30.21 | 1.5% | n/a | US$8.4b | US$32.88 | PS18.6x | E72.6% | n/a | ||
TWST | US$27.63 | 7.8% | -35.3% | US$1.5b | US$42.44 | PS4.6x | E47.0% | n/a | ||
LENZ | US$38.77 | 11.8% | 67.3% | US$989.1m | US$50.88 | PS221.2x | E59.4% | n/a | ||
ARWR | US$17.21 | 4.8% | -25.0% | US$2.3b | US$43.79 | PS4.2x | E-9.9% | n/a | ||
SION | US$20.03 | 13.4% | n/a | US$779.1m | US$38.50 | PB2.5x | E-13.6% | n/a | ||
SNDL | US$2.01 | 19.6% | -5.6% | US$517.3m | US$4.49 | PB0.7x | E161.2% | n/a | ||
ICLR | US$159.71 | 0.8% | -48.8% | US$12.3b | US$218.80 | PE15.6x | E7.7% | n/a | ||
AMRX | US$8.84 | 3.5% | 17.2% | US$2.7b | US$12.00 | PE822.7x | E80.6% | 0% | ||
TARS | US$50.07 | 4.6% | 91.0% | US$2.0b | US$73.88 | PS7.2x | E61.8% | n/a | ||
CMPX | US$3.34 | 23.7% | 195.6% | US$373.4m | US$13.10 | PS543.4x | E49.4% | n/a | ||
MDGL | US$349.50 | 1.1% | 44.4% | US$7.7b | US$438.43 | PS15.1x | E64.5% | n/a | ||
INVA | US$19.65 | 7.1% | 7.7% | US$1.2b | US$41.00 | PE32x | E32.2% | 0% | ||
ABCL | US$4.50 | 5.9% | 68.5% | US$1.3b | US$9.29 | PS40.9x | E2.3% | n/a | ||
GPCR | US$17.51 | 7.4% | -47.2% | US$939.4m | US$73.08 | PB1.3x | E14.5% | n/a | ||
ANIP | US$84.88 | 4.2% | 42.2% | US$1.6b | US$90.50 | PS2.3x | E41.7% | n/a | ||
LQDA | US$21.20 | 3.7% | 73.6% | US$1.7b | US$30.30 | PS128.1x | E66.2% | n/a | ||
MLTX | US$53.38 | 1.9% | 17.8% | US$3.3b | US$77.86 | PB9.6x | E43.6% | n/a | ||
XERS | US$7.20 | 5.3% | 183.5% | US$1.2b | US$7.80 | PS4.7x | E57.8% | n/a | ||
OCUL | US$12.56 | 2.9% | 57.2% | US$2.1b | US$17.67 | PS38.6x | E29.4% | n/a | ||
QURE | US$14.12 | 6.3% | 100.6% | US$961.6m | US$33.44 | PS67.1x | E60.7% | n/a | ||
NUVL | US$74.95 | 1.1% | 3.9% | US$5.3b | US$116.27 | PB5.8x | E37.9% | n/a | ||
VSTM | US$7.70 | 14.2% | 231.9% | US$414.8m | US$15.38 | PS221.8x | E54.9% | n/a | ||
PBYI | US$4.85 | 31.4% | 40.0% | US$185.9m | US$3.00 | PE5x | E-34.1% | n/a |